Summary
- Main use
- Pain control through dental anesthesia (such as local and infiltration anesthesia)
- Who receives it
- Adults · Children
- Adult administration
- Administer by local injection into the oral mucosa or by regional injection. Perform an aspiration test to ensure that the injection is not being administered into a blood vessel. The injection rate must not exceed 1mL per minute. The recommended doses for routine procedures are shown in Table 1. The actual dose used depends on the type and extent of the surgical procedure, depth of anesthesia, degree of muscle relaxation, and the patient's condition. In all cases, administer the lowest dose that achieves the desired result. Do not exceed 7mg/kg of articaine hydrochloride. [Table 1] Recommended doses are for guidance only. Infiltration: 0.5~2.5 mL, total articaine hydrochloride dose 20~100 mg Nerve block: 0.5~3.4 mL, total articaine hydrochloride dose 20~136 mg Oral surgery: 1.0~5.1 mL, total articaine hydrochloride dose 40~204 mg
- Child administration
- Children, 4 years and older: Determine the anesthetic dose according to age, body weight, and type of procedure. The average dose of articaine hydrochloride (mg) is calculated using the following formula: articaine hydrochloride (mg) = child's body weight ×1.33. The maximum dose must not exceed 5mg/kg of articaine hydrochloride (0.125ml of this medicine).
Ingredients
- Manufacturer
- Huons Co., Ltd.
Efficacy & effects
Pain control through dental anesthesia (such as local and infiltration anesthesia)
View approved original textHide original text
Used for local anesthesia, infiltration anesthesia, and conduction anesthesia to reduce pain during dental treatment. Local anesthesia selectively blocks sensation in specific areas to alleviate pain, while infiltration anesthesia injects the anesthetic around the gums to block nerves in the local area. Conduction anesthesia blocks the pathways through which nerves transmit signals across a broader area, inducing a more extensive state of pain relief. These anesthetic methods help ensure patient comfort during dental treatments or surgeries, maximizing therapeutic effects. Therefore, these methods are used for safe and effective pain management in dental treatments.
How it is given
Adult administration
Administer by local injection into the oral mucosa or by regional injection. Perform an aspiration test to ensure that the injection is not being administered into a blood vessel. The injection rate must not exceed 1mL per minute. The recommended doses for routine procedures are shown in Table 1. The actual dose used depends on the type and extent of the surgical procedure, depth of anesthesia, degree of muscle relaxation, and the patient's condition. In all cases, administer the lowest dose that achieves the desired result. Do not exceed 7mg/kg of articaine hydrochloride. [Table 1] Recommended doses are for guidance only. Infiltration: 0.5~2.5 mL, total articaine hydrochloride dose 20~100 mg Nerve block: 0.5~3.4 mL, total articaine hydrochloride dose 20~136 mg Oral surgery: 1.0~5.1 mL, total articaine hydrochloride dose 40~204 mg
Child administration
Children, 4 years and older: Determine the anesthetic dose according to age, body weight, and type of procedure. The average dose of articaine hydrochloride (mg) is calculated using the following formula: articaine hydrochloride (mg) = child's body weight ×1.33. The maximum dose must not exceed 5mg/kg of articaine hydrochloride (0.125ml of this medicine).
Precautions
This medication should not be administered via intravenous injection. If mistakenly injected intravenously, severe seizures, central nervous system and cardiac respiratory function impairment may occur, potentially leading to respiratory failure. When using this medication, resuscitation equipment and oxygen supply devices must be prepared in case of emergencies. Patients with hypertension or diabetes should be cautious when using this medication due to the risk of local tissue necrosis. Do not administer this medication to patients with known allergies to this drug, amide type local anesthetics, or its components. Particularly, patients allergic to sodium metabisulfite may experience severe allergic reactions such as anaphylaxis, so administration should be avoided. It should not be used in patients with cardiac conduction disorders not compensated by a pacemaker, those with intermittent acute porphyrias, uncontrolled epilepsy, children under 4 years old, patients contraindicated for concomitant use with guanethidine and similar drugs, those with cardiovascular disease, hyperthyroidism, uncontrolled severe diabetes, myasthenia gravis, patients concomitantly taking monoamine oxidase inhibitors or tricyclic antidepressants, or those likely to require general anesthesia. For patients on anticoagulants, there may be an increased risk of bleeding, so careful administration is required. Special care is needed for patients with cardiovascular issues, such as those with arrhythmias, coronary insufficiency, severe hypertension, and those with liver dysfunction, as drug metabolism may slow, leading to toxicity; dosage adjustments may be necessary. Dosages should also be reduced for patients with hypoxia, hyperkalemia, or metabolic acidosis. Patients with a history of epilepsy or lung diseases, particularly allergic asthma, should exercise caution due to the potential for allergic reactions to the components of this medication. Hyperthyroidism and diabetic patients are not recommended to use this medication because of the adrenaline component. Patients taking phenothiazine agents should be careful as combined use may reduce the vasoconstrictive effects of this medication. Patients on non-selective beta-blockers should also be cautious due to the risk of increased blood pressure. When using this medication, it is important to confirm the patient's constitution and allergy history, and to conduct a test injection in small amounts if there is a risk of allergy. When injecting, it is critical to inject slowly to avoid intravascular administration, and to continuously communicate with the patient to detect adverse reactions early. It is recommended not to inject into infected or inflamed areas, and to refrain from eating until normal sensation in the anesthetic area is restored. This medication may yield a positive result in doping tests, so athletes should be informed about this. It is contraindicated for combination with certain medications such as guanethidine, and caution is required when used with some antidepressants and monoamine oxidase inhibitors. During pregnancy, due to insufficient confirmation of safety for the fetus, this medication should only be used when its benefits outweigh the risks; caution is also needed during breastfeeding. This medication may affect reaction ability when driving or operating machinery, so caution is advised. In case of overdose, immediate oxygen supply and airway management are necessary; if seizures persist, anticonvulsants should be administered, and intubation may be needed as necessary. Finally, this medication must have its septum disinfected with alcohol before use, it should not be submerged in liquid or mixed with other drugs, and cartridges should not be reused after use.
Side effects
- Headache
- abnormal sensation in the lips or tongue
- sensory loss
- tremors
- pathological talkativeness
- metallic taste
- dizziness
- coma
- facial paralysis
- drowsiness
Show 42 moreCollapse
- irritability
- anxiety
- restlessness
- confusion
- agitation
- increased respiratory rate
- respiratory paralysis
- yawning
- rapid pulse
- slow pulse
- myocardial depression
- cardiac arrest
- angina
- rapid arrhythmia
- palpitations
- hypotension
- hypertension
- double vision
- pupil dilation
- ptosis
- pupil constriction
- enophthalmos
- eye twitching
- tinnitus
- nausea
- vomiting
- diarrhea
- facial swelling
- itching
- vascular edema
- tissue necrosis
- facial flushing
- muscle fasciculations
- tonic-clonic seizures
- acute thyroid swelling
- warmth
- allergic reaction
- anaphylactic shock
- pain
- ulcerative stomatitis
- hypoglycemia
- tremors
Not everyone experiences these, and they can vary from person to person.
Storage
Store this medication in a container that does not allow light, as it is sensitive to light. It is crucial to store it in a cool place, maintaining a storage temperature between 1 and 25 degrees Celsius, and avoiding extremely hot or cold places.
Appearance and packaging
Appearance
A colorless ampoule injection with a colorless cartridge filled with a clear liquid.
Package unit
- For domestic use: 1.7mL x 50 cartridge-type ampoules - For export: 1.7mL x 100 cartridge-type ampoules
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.